App-Quantinova.ai

Functional Relationship of the COL4A1/COL4A2 Locus on Chromosome 13q34 to Coronary Artery Disease (CAD)

Majid Nikpay - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

SB431542

Practice Patterns and Trends in the Use of Medical Therapy in Patients Undergoing Percutaneous Coronary Intervention

Lingsong Yun - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Stable coronary artery disease

N/A

Aortic Pulse Wave Velocity Measurement by Doppler Technique During Transesophageal Echocardiography Examination: A Feasible and Reproducible Method

Jacques Somma - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arterial stiffness

N/A

The Immunoregulatory Cytokine FGL2 is Associated With Functional Impairment in Patients With Heart Failure

Douglas Greig - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Ischemic cardiomyopathy

Fibrinogen (IV)

The Economic Impact of Healthcare Associated Infections in Cardiac Surgery

Wei Shi - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Sepsis

N/A

Embryonic Origins of Vascular Progenitors in the Adult Murine Aorta

Martha H Carruthers - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Spinocerebellar ataxia 1

stannous fluoride

Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate in Adolescents: An Open-label Phase IIa Study

Thorsten Lehr - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Pradax

Determinants of Cardiac Loading During Long Duration Spaceflight

Jeffrey L Hastings - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

S100A1 Released From Ischemic Cardiomyocytes Signals Myocardial Damage and Functions as Cardiac Alarmin

Christoph Schon - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

Interleukin-10

Cost-effectiveness of Apixaban Against Dabigatran and Rivaroxaban for Stroke Prevention in Non-valvular Atrial Fibrillation Patients

Tereza Lanitis - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Non-valvular atrial fibrillation

rivaroxaban

Normal c-Myb Activity is Critical for Both Vessel-Resident and Bone Marrow-Derived Cell Responses to Arterial Remodeling Following Injury

Abdul Momen - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Intimal hyperplasia

N/A

Safety Aspects of High Intensity Interval Training versus Moderate Intensity Continuous Exercise Training in Patients Post Acute Coronary Syndrome

Mathieu Gayda - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

N/A

Utilization of High-Potency Statin Therapy Following Hospitalization for CHD Among Medicare Beneficiaries

Shia Kent - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

Atorvastatin

Efficacy of Dabigatran versus Warfarin in Patients With Acute Venous Thromboembolism and Thrombophilia: A Pooled Analysis of RE-COVER and RE-COVER II

Sam Schulman - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Pradax

Role for RUNX2 in Pulmonary Arterial Hypertension

Sophie Chabot - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

N/A

Exome Chip Analysis From the CASPER Registry Highlights Potential Genetic Variant Associated With Unexplained Cardiac Arrest

Andrew D Krahn - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

N/A

MiR-223 Improves Experimental Pulmonary Arterial Hypertension

Jolyane Meloche - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

Monocrotaline

Fibulin-4 Deficiency Alters Collagen Regulation in the Aortic Wall

Lea-Jeanne Ringuette - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Aortic aneurysm, familial thoracic 4

N/A

Frequency and Contributing Factors to Diaphragm Paresis Following Pediatric Cardiac Surgery

Osami Honjo - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac arrest

N/A

Effects of Prolonged Space Flight on Cardiac Structure and Function

Jeffrey L Hastings - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Myocardial fibrosis

N/A

Filters

28841 Abstracts